ARTICLE | Company News
HistoRx, Metamark Genetics deal
January 3, 2011 8:00 AM UTC
Metamark received worldwide rights to HistoRx's AQUA fluorescent immunohistochemistry technology to commercialize Metamark's MetamarkDx Prognostic Assays. The assays identify patient tumor profiles th...